A Phase II Randomized Therapeutic Optimization Trial for Subjects With Refractory Metastatic Cancers Using ctDNA: Rapid 1 Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Metastatic Colorectal Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 99 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04786600
- Collaborators
- Natera, Inc.
- Investigators
- Principal Investigator: Carmen Allegra, MD University of Florida
Get Well Soon